[Federal Register Volume 69, Number 129 (Wednesday, July 7, 2004)]
[Notices]
[Page 40943]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-15386]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement Number 04100]


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Prevention Epicenter Program--Microbiology Errors 
Associated With Processing Blood and Sterile Body Site Cultures--The 
Impact of New Forms of Antimicrobial Use, Resistance, Laboratory 
Methods, and Infection Control Practices on the Incidence of 
Clostridium Difficile and Associated Patient Morbidity and Healthcare 
Costs

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting: Prevention Epicenter 
Program--Microbiology Errors Associated with Processing Blood and 
Sterile Body Site Cultures--The Impact of New Forms of Antimicrobial 
Use, Resistance, Laboratory Methods, and Infection Control Practices on 
the Incidence of Clostridium difficile and Associated Patient Morbidity 
and Healthcare Costs, Program Announcement Number 04100.

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP).
    Times and Dates: 8 a.m.-8:30 a.m., July 27, 2004 (Open). 8:45 
a.m.-3:30 p.m., July 27, 2004 (Closed).
    Place: Marriott Airport Hotel, 4711 Best Road, College Park, GA 
30337, Telephone number 404-766-7900.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in Section 552b(c)(4) and (6), 
Title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Pub. L. 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Program Announcement Number 04100.
    For Further Information Contact: Trudy Messmer, Ph.D., 
Scientific Review Administrator, National Center for Infectious 
Diseases, CDC, 1600 Clifton Road, NE., MS-C19, Atlanta, GA 30333, 
Telephone 404-639-2176.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: June 29, 2004.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 04-15386 Filed 7-6-04; 8:45 am]
BILLING CODE 4163-18-P